Some risk in the value of the scrip, but overall a great arbitrage on offer. I certainly wouldn't be buying PRG at these prices when you can buy it indirectly through SKE!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025